- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to…
Garching / Munich, Germany, August 19, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced…
BEIJING, Aug. 15, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) showcased its latest achievements…
Listed in the prestigious international academic journal, MDPI 'Prosthesis' SEOUL, South Korea, Aug. 6, 2025 /PRNewswire/ -- Osstem Implants, the…
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…
MUMBAI, India, Aug. 1, 2025 /PRNewswire/ -- The Credit Guarantee Fund Trust for Micro and Small Enterprises (CGTMSE), marking 25 years…
PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of…
SINGAPORE, July 23, 2025 /PRNewswire/ -- Panduit Corp has been awarded the prestigious Asia Responsible Enterprise Award (AREA) 2025 under…
– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase…